Our skilled team offers accepted treatments for various retinal conditions.

Here are some of the services we provide:

Laser Treatment for Retinal Tears

When retinal tears occur, laser therapy can help seal the tear and prevent further complications. It’s a quick and effective outpatient procedure. If the tear has progressed beyond a tear into a retinal detachment, a prompt referral to the retinal service for vitrectomy will be needed.

Laser Treatment for Diabetic Retinopathy

Diabetic retinopathy damages blood vessels in the retina. Laser treatment (photocoagulation) targets these abnormal vessels, reducing the risk of vision loss.

Retinal injections involve the direct delivery of medication into the eye to manage various retinal conditions. These injections target abnormal blood vessels, inflammation, and swelling within the
retina. At Garrett Eye Center, we have done many thousands of injections dating back to the very1st FDA approvals of their safety and effectiveness.

We offer many effective options not limited to below:

Avastin (Bevacizumab)

Purpose: Originally approved for cancer treatment, Avastin is now used “off-label” to treat eye diseases.
Mechanism: It blocks the growth and leakage of fluid from abnormal blood vessels in the retina.
Conditions Treated:

• Wet age-related macular degeneration (AMD)
• Diabetic eye disease
• Other retinal conditions

Administration: Injected directly into the eye by an ophthalmologist.
Safety: Many studies have shown Avastin to be safe and effective for eye diseases.

Eylea (Aflibercept)

Purpose: Specifically approved for wet AMD, Eylea also treats diabetic eye disease and other retinal issues.
Mechanism: Blocks VEGF (vascular endothelial growth factor), slowing abnormal blood vessel growth.
Treatment Process:

• Outpatient procedure
• Eye numbed to prevent pain
• Eylea injected directly into the eye
• May require multiple injections over months

Combination Therapy: Sometimes combined with other treatments for optimal results.

Syfovre (Pegcetacoplan)

Purpose: 1st drug FDA-approved for treating geographic atrophy (GA), the dry advanced form of AMD.
Mechanism: Syfovre is a complement inhibitor that slows the growth of GA lesions, preserving vision and reducing significant vision loss and blindness.
GA Lesions: These damaged areas in the retina result from age-related macular degeneration. Over time, they can spread to the central retina (fovea), causing vision loss.
Mode of Action: Syfovre inhibits C3, a protein in the complement system, which is overactive in AMD and damages retinal cells. By controlling C3, Syfovre slows lesion progression.

Iluvien (fluocinolone acetonide)

Iluvien is a sustained release implant that delivers corticosteroids to manage diabetic retinopathy

Our commitment to excellence ensures that you receive personalized care tailored to your unique needs. Contact us today to schedule your retinal evaluation and explore the innovative solutions available at Garrett Eye Center.